Clinical Trial: Clinical Study on the Safety and Preliminary Efficacy of CDH17/GUCY2C CAR-T in the Treatment of Patients With Advanced Colorectal Cancer

U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07152210) titled 'Clinical Study on the Safety and Preliminary Efficacy of CDH17/GUCY2C CAR-T in the Treatment of Patients With Advanced Colorectal Cancer' on Aug. 26.

Brief Summary: This study is a single-arm, single-center investigator-initiated trial (IIT) designed to evaluate the safety and preliminary efficacy of CDH17/GUCY2C CAR-T cell therapy in patients with advanced colorectal cancer, as well as to assess its pharmacodynamic (PD) and pharmacokinetic (PK) profiles.

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Colorectal Cancer (CRC)

Intervention: BIOLOGICAL: CAR-T

Eligible subjects who successfully passed screening ...